Literature DB >> 17542449

Establishing a viral hepatitis prevention and control program: Florida's experience.

Linda M Baldy1, Cheryl Urbas, Jennie L Harris, T Stephen Jones, Philip E Reichert.   

Abstract

In 1999, the Florida State Legislature established and funded the statewide Hepatitis Prevention Program (HPP) to address growing concern about hepatitis C virus (HCV) and its potential public health burden. HPP supports county health departments' (CHDs') provision of viral hepatitis prevention services to at-risk adults through free hepatitis A and B vaccine in most CHDs and hepatitis serologic testing and statewide viral hepatitis-related education, consultation, and referral services. Some CHDs are directly funded by HPP. In 2001-2005, HPP support helped CHDs provide 59,228 hepatitis A and 74,039 hepatitis B vaccinations statewide. In 2005, HPP supported almost 17,000 hepatitis B and C tests. From January to June 2005, 1,603 positive HCV tests were reported, a 9.5% seropositivity rate. With $24 million from the Florida State Legislature through 2006, HPP has helped CHDs statewide provide substantial viral hepatitis prevention services to at-risk adults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17542449      PMCID: PMC1831811          DOI: 10.1177/00333549071220S205

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  4 in total

1.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

Authors:  Miriam J Alter; Wendi L Kuhnert; Lyn Finelli
Journal:  MMWR Recomm Rep       Date:  2003-02-07

2.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Authors:  Eric E Mast; Cindy M Weinbaum; Anthony E Fiore; Miriam J Alter; Beth P Bell; Lyn Finelli; Lance E Rodewald; John M Douglas; Robert S Janssen; John W Ward
Journal:  MMWR Recomm Rep       Date:  2006-12-08

3.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-16

4.  Texas statewide hepatitis C counseling and testing, 2000-2005.

Authors:  Gary Heseltine; Jenny McFarlane
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

  4 in total
  6 in total

1.  Advancing integration of HIV, STD, and viral hepatitis services: state perspectives.

Authors:  Peter Whiticar; Thomas Liberti
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

2.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

3.  Managing chronic hepatitis C in primary-care settings: more than antiviral therapy.

Authors:  Barry Zevin
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

4.  CDC and progress toward integration of HIV, STD, and viral hepatitis prevention.

Authors:  John W Ward; Kevin A Fenton
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

5.  The costs and impacts of testing for hepatitis C virus antibody in public STD clinics.

Authors:  Amanda A Honeycutt; Jennie L Harris; Olga Khavjou; Joanna Buffington; T Stephen Jones; David B Rein
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

6.  Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico.

Authors:  Sanjeev Arora; Karla Thornton; Steven M Jenkusky; Brooke Parish; Joseph V Scaletti
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.